ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 356 filers reported holding ENCOMPASS HEALTH CORP in Q3 2019. The put-call ratio across all filers is 2.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $263,000 | -4.0% | 3,506 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $274,000 | -64.9% | 3,506 | -63.2% | 0.00% | -75.0% |
Q1 2021 | $780,000 | -13.2% | 9,520 | -12.5% | 0.00% | -20.0% |
Q4 2020 | $899,000 | +27.2% | 10,876 | -0.1% | 0.01% | +25.0% |
Q3 2020 | $707,000 | +4.9% | 10,887 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $674,000 | -3.3% | 10,887 | -0.0% | 0.00% | -20.0% |
Q1 2020 | $697,000 | +358.6% | 10,890 | +396.4% | 0.01% | +400.0% |
Q4 2019 | $152,000 | +9.4% | 2,194 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $139,000 | -84.4% | 2,194 | -84.4% | 0.00% | -75.0% |
Q2 2019 | $892,000 | -93.7% | 14,083 | -94.2% | 0.00% | -93.7% |
Q1 2019 | $14,116,000 | -35.7% | 241,711 | -32.0% | 0.06% | -38.2% |
Q4 2018 | $21,940,000 | -28.8% | 355,585 | -10.1% | 0.10% | -12.1% |
Q3 2018 | $30,826,000 | +248.6% | 395,454 | +202.8% | 0.12% | +231.4% |
Q2 2018 | $8,844,000 | -53.7% | 130,599 | -60.9% | 0.04% | -53.3% |
Q1 2018 | $19,089,000 | +5.3% | 333,903 | -9.0% | 0.08% | +10.3% |
Q4 2017 | $18,130,000 | – | 366,928 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Copeland Capital Management, LLC | 569,048 | $28,117,000 | 1.78% |
Kalos Management, Inc. | 76,118 | $3,761,000 | 1.77% |
Bridge City Capital, LLC | 30,231 | $1,494,000 | 1.08% |
DALTON GREINER HARTMAN MAHER & CO | 331,823 | $16,395,000 | 0.86% |
Horrell Capital Management, Inc. | 28,641 | $1,415,000 | 0.74% |
Polianta Ltd | 26,600 | $1,314,000 | 0.43% |
GLOBEFLEX CAPITAL L P | 30,177 | $1,491,000 | 0.42% |
CARILLON TOWER ADVISERS, INC. | 768,748 | $37,984,000 | 0.40% |
EAGLE ASSET MANAGEMENT INC | 1,070,271 | $53,001,000 | 0.29% |
S. R. Schill & Associates | 8,108 | $401,000 | 0.25% |